Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial von Monk, Bradley J, Toita, Takafumi, Wu, Xiaohua, Vázquez Limón, Juan C, Tarnawski, Rafal, Mandai, Masaki, Shapira-Frommer, Ronnie, Mahantshetty, Umesh, del Pilar Estevez-Diz, Maria, Zhou, Qi, Limaye, Sewanti, Godinez, Francisco J Ramirez, Oppermann Kussler, Christina, Varga, Szilvia, Valdiviezo, Natalia, Aoki, Daisuke, Leiva, Manuel, Lee, Jung-Yun, Sulay, Raymond, Kreynina, Yulia, Cheng, Wen-Fang, Rey, Felipe, Rong, Yi, Ke, Guihao, Wildsmith, Sophie, Lloyd, Andrew, Dry, Hannah, Tablante Nunes, Ana, Mayadev, Jyoti

Volltext

BEGONIA: Phase 1b/2, open-label, platform study of the safety and efficacy of durvalumab (D) ± paclitaxel (P) with novel oncology therapies for first-line metastatic triple-negativ... von Schmid, Peter, Nunes, Ana Tablante, Dry, Hannah, Dougherty, Rachel, Karwe, Vatsala, Scheuring, Urban J.

Volltext

5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLC von Velcheti, Vamsidhar, Rai, Pragya, Kao, Yu-Han, Chirovsky, Diana, Nunes, Ana Tablante, Liu, Stephen V.

Volltext

Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review von Pujade-Lauraine, Eric, Tan, David S.P., Leary, Alexandra, Mirza, Mansoor Raza, Enomoto, Takayuki, Takyar, Jitender, Nunes, Ana Tablante, Chagüi, José David Hernández, Paskow, Michael J., Monk, Bradley J.

Volltext

BEGONIA: Phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC)—Initial results from arm 1, d+paclitaxel (P), and arm 6... von Schmid, Peter, Im, Seock-Ah, Armstrong, Anne, Park, Yeon Hee, Chung, Wei-Pang, Nowecki, Zbigniew, Lord, Simon, Wysocki, Piotr Jan, Lu, Yen-Shen, Dry, Hannah, Karwe, Vatsala, Stewart, Ross, Herbolsheimer, Pia, Nunes, Ana Tablante, Jung, Kyung Hae

Volltext

Phase 1 study of intraperitoneal infusion of autologous monocytes with peginterferon alfa-2b and interferon gamma-1b in women with recurrent or refractory ovarian cancer, fallopian... von Nunes, Ana Tablante, Green, Daniel, Ekwede, Irene, Zoon, Kathryn, Annunziata, Christina M.

Volltext

A phase I dose expansion cohort study of dasatinib in combination with bevacizumab in advanced solid tumors (NCT01445509) von Osei-Tutu, Akosua, Nunes, Ana Tablante, Lee, Jung-min, Yu, Minshu, Hernandez, Lidia, Chen, Helen X., Takebe, Naoko, Houston, Nicole D., Ekwede, Irene, Steinberg, Seth M., Chen, Jin-Qiu, Cao, Liang, Figg, W. Douglas, Butcher, Donna, Annunziata, Christina M., Kohn, Elise C.

Volltext

Gene Expression Assays for Early-Stage Hormone Receptor–Positive Breast Cancer: Understanding the Differences von Nunes, Ana Tablante, Collyar, Deborah E, Harris, Lyndsay N

Volltext

Informed Consent for Research: A Cross-Sectional Survey on the Views of Parents of Sick Newborns von Nunes, Ana Tablante, Trahms, Christine F., D'Angio, Carl T.

Volltext